Trials / Completed
CompletedNCT01448460
Oocyte Vitrification for In Vitro Fertilization (IVF) Patients and Women With Fertility Threatening Conditions
Oocyte Vitrification for IVF Patients and Women With Fertility Threatening Conditions
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- University of Louisville · Academic / Other
- Sex
- Female
- Age
- 14 Years – 42 Years
- Healthy volunteers
- Not accepted
Summary
Vitrification is a method of cryopreserving tissue for future use. It is widely used to preserve extra, good quality embryos generated from infertility treatments. It is becoming popular for the preservation of oocytes (eggs) as well, but is still considered investigational in this respect. The purpose of this study is to provide egg freezing for patients desiring fertility preservation. Although commonly used in clinics around the world, it should be offered as an IRB approved study procedure until it is no longer considered investigational by the American Society of Reproductive Medicine.
Conditions
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2011-10-07
- Last updated
- 2013-01-24
Source: ClinicalTrials.gov record NCT01448460. Inclusion in this directory is not an endorsement.